Invest in the future of diagnostic innovation

MS Pen Technologies, Inc. is a medical technology developing AI-powered tissue sensing and diagnostics devices. MS Pen Technologies is at the intersection of technology and biology (“tech-bio”) seeking to accelerate time to results and improve patient outcomes. Our proprietary tech, MasSpec PenTM, is a revolutionary device that has been used by 20+ surgeons in over 200+ cancer patients that delivered surgical margin analysis in real-time.* The time is now to transform healthcare through innovation!

We are always open to hearing from companies and investors who share our vision and passion for diagnostic innovation.

Please contact us to explore ways that we can work together to transform healthcare!


* The MasSpec Pen has not been approved by the FDA and should be used for research purposes only. These studies were conducted under IRB oversight.

Our inbox is always open

Request Info

If you are interested in learning more about MS Pen Technologies, our diagnostic platform, or investment and partnership opportunities, please feel free to reach out.